Medical Affairs

Strategic pillar of pharmaceutical and biotech companies

 

The call for Real World Evidence (RWE) data and Health Economic Outcome Research (HEOR), as well as the need to communicate more and more medical-scientific data to different stakeholders (physicians, patients, payers), makes Medical Affairs an important strategic pillar of pharmaceutical and biotech companies.

Medical Science Liaisons (MSLs) are the most important link between Health Care Providers (HCPs) and companies and are the fastest growing role.

Processes and structures of the organization must be adapted accordingly. Competencies, knowledge and working methods of the employees, but also the cross-functional cooperation of the different departments must be developed and trained. Communication concepts with external stakeholders should be rethought at least since Corona.

Dr. Annette Athari Medical Affairs Consulting Partner is specialized in consulting, coaching and training for pharmaceutical and biotech companies around the needs of medical affairs organizations. Together with you and my partners we develop forward-looking and customized solutions for the benefit of patients, health care professionals and your company.


You are looking for support

in the strategic positioning of medical affairs in your company?

  • Establishment, expansion or further development of medical affairs organizations

  • Processes and structures for improved cooperation with stakeholders in the company

to increase the effectiveness of your medical affairs department, especially your MSL team?

  • Improving cooperation with HCPs

  • Further development of skills, knowledge and working methods of the Medical Affairs team

  • Optimization of the Medical Affairs organizational structures

  • Improvement of internal and cross-functional cooperation